455 related articles for article (PubMed ID: 8706374)
1. Ionic mechanisms of ischemia-related ventricular arrhythmias.
Ducceschi V; Di Micco G; Sarubbi B; Russo B; Santangelo L; Iacono A
Clin Cardiol; 1996 Apr; 19(4):325-31. PubMed ID: 8706374
[TBL] [Abstract][Full Text] [Related]
2. [Ion channels and arrhythmias].
Borchard U; Hafner D
Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780
[TBL] [Abstract][Full Text] [Related]
3. Symposium on the management of ventricular dysrhythmias. Concept of reentry versus automaticity.
Sasyniuk BI
Am J Cardiol; 1984 Jul; 54(2):1A-6A. PubMed ID: 6380258
[TBL] [Abstract][Full Text] [Related]
4. Role of alterations in refractoriness and conduction in the genesis of reentrant arrhythmias. Implications for antiarrhythmic effects of class III drugs.
Wit AL; Coromilas J
Am J Cardiol; 1993 Nov; 72(16):3F-12F. PubMed ID: 8237828
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiology of arrhythmias.
Janse MJ
Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():9-16. PubMed ID: 10326153
[TBL] [Abstract][Full Text] [Related]
6. Mechanism-specific antiarrhythmic effects of the potassium channel activator levcromakalim against repolarization-dependent tachycardias.
Vos MA; Gorgels AP; Lipcsei GC; De Groot SH; Leunissen JD; Wellens HJ
J Cardiovasc Electrophysiol; 1994 Sep; 5(9):731-42. PubMed ID: 7827712
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiologic mechanisms for ventricular arrhythmias in left ventricular dysfunction: electrolytes, catecholamines and drugs.
Levy MN; Wiseman MN
J Clin Pharmacol; 1991 Nov; 31(11):1053-60. PubMed ID: 1753009
[TBL] [Abstract][Full Text] [Related]
8. Current antiarrhythmic drugs: an overview of mechanisms of action and potential clinical utility.
Singh BN
J Cardiovasc Electrophysiol; 1999 Feb; 10(2):283-301. PubMed ID: 10090235
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiological basis for antiarrhythmic drug action.
Wit AL
Clin Physiol Biochem; 1985; 3(2-3):127-34. PubMed ID: 3891195
[TBL] [Abstract][Full Text] [Related]
10. [New aspects of the molecular effect of anti-arrhythmia agents].
Honerjäger P
Herz; 1990 Apr; 15(2):70-8. PubMed ID: 2160907
[TBL] [Abstract][Full Text] [Related]
11. Why are some antiarrhythmic drugs proarrhythmic? Cardiac arrhythmia study by bifurcation analysis.
Chay TR
J Electrocardiol; 1995; 28 Suppl():191-7. PubMed ID: 8656110
[TBL] [Abstract][Full Text] [Related]
12. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
Cimponeriu A; Starmer CF; Bezerianos A
IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
[TBL] [Abstract][Full Text] [Related]
13. The antiarrhythmic and antifibrillatory effects of calcium antagonists.
Billman GE
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S107-17. PubMed ID: 1724998
[TBL] [Abstract][Full Text] [Related]
14. The molecular and ionic specificity of antiarrhythmic drug actions.
Nattel S
J Cardiovasc Electrophysiol; 1999 Feb; 10(2):272-82. PubMed ID: 10090234
[TBL] [Abstract][Full Text] [Related]
15. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms.
Masotti CS; Pierangeli A
Panminerva Med; 1999 Dec; 41(4):295-306. PubMed ID: 10705709
[TBL] [Abstract][Full Text] [Related]
16. [Pathophysiology of cardiac arrhythmias].
Antoni H
Z Kardiol; 1992; 81 Suppl 4():111-7. PubMed ID: 1290287
[TBL] [Abstract][Full Text] [Related]
17. [New aspects of the electrophysiologic effect of antiarrhythmic agents].
Antoni H; Weirich J
Herz; 1990 Apr; 15(2):61-9. PubMed ID: 2188893
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic basis for arrhythmias in ischemic heart disease.
Lazzara R; Scherlag BJ
Am J Cardiol; 1984 Feb; 53(5):1B-7B. PubMed ID: 6364766
[TBL] [Abstract][Full Text] [Related]
19. Use of calcium antagonists for cardiac arrhythmias.
Singh BN; Nademanee K
Am J Cardiol; 1987 Jan; 59(3):153B-162B. PubMed ID: 2433930
[TBL] [Abstract][Full Text] [Related]
20. Antiarrhythmic action of beta-blockers: potential mechanisms.
Dorian P
J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S15-22. PubMed ID: 15965568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
